FFA
IBRX icon

Farther Finance Advisors’s ImmunityBio IBRX Stock Holding History

Farther Finance Advisors’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$156K Buy
16,482
+287
+2% +$2.29K ﹤0.01% 2500
2026
Q2 		$142K Buy
16,195
+655
+4% +$4.96K ﹤0.01% 2475
2026
Q1 		$111K Buy
+15,540
New +$106K ﹤0.01% 2436
2025
Q2 		– Sell
-434
Closed -$1.28K – 4570
2025
Q1 		$1.28K Buy
434
+428
+7,133% +$1.3K ﹤0.01% 3539
2024
Q4 		$15 Buy
6
+5
+500% +$21 ﹤0.01% 3948
2024
Q3 		$4 Buy
+1
New +$5 ﹤0.01% 3968

Other funds holding IBRX

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $458M AUM 38.24% 1-Year Est. Return
MWM
MFG Wealth Management Indianapolis, Indiana $138M AUM 31.54% 1-Year Est. Return
CFO
Collective Family Office York, Pennsylvania $484M AUM 13.93% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $2.57B AUM 28.13% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $532M AUM 15.78% 1-Year Est. Return
GWSA
Global Wealth Strategies & Associates Denver, Colorado $546M AUM 14.96% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
PCA
Private Capital Advisors Darien, Connecticut $1.15B AUM 43.46% 1-Year Est. Return
FWP
Firethorn Wealth Partners Augusta, Georgia $313M AUM 15.55% 1-Year Est. Return

Farther Finance Advisors's IBRX Position: Q3 2026 in Review

Farther Finance Advisors increased its ImmunityBio (IBRX) stake by 1.8% in Q3 2026, buying an estimated $2.29K and bringing the position to 16,482 shares worth $156K. The position accounts for ﹤0.01% of the portfolio, ranked #2500.

Farther Finance Advisors first reported a position in IBRX in Q3 2024 and has held it in 6 quarters since. 27 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.

  • Farther Finance Advisors held 16,482 shares of ImmunityBio worth $156K as of Q3 2026.
  • Farther Finance Advisors bought 287 ImmunityBio shares in Q3 2026, an estimated $2.29K.
  • ImmunityBio made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #2500 holding.
  • Farther Finance Advisors first reported a position in ImmunityBio in Q3 2024 and has held it in 6 quarters since.
  • 27 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.